Eventide Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.1M | Sell |
1,424,282
-451,957
| -24% | -$19.1M | 0.78% | 42 |
|
|
2025
Q4 | $86.9M | Sell |
1,876,239
-514,673
| -22% | -$21.5M | 1.36% | 15 |
|
|
2025
Q3 | $83.7M | Sell |
2,390,912
-250,489
| -9% | -$8.71M | 1.38% | 17 |
|
|
2025
Q2 | $78.1M | Buy |
2,641,401
+1,854
| +0.1% | +$52.9K | 1.37% | 16 |
|
|
2025
Q1 | $78.8M | Buy |
2,639,547
+845
| +0% | +$25.8K | 1.57% | 12 |
|
|
2024
Q4 | $75.6M | Buy |
2,638,702
+3,296
| +0.1% | +$109K | 1.38% | 19 |
|
|
2024
Q3 | $102M | Buy |
2,635,406
+750
| +0% | +$26.7K | 1.76% | 12 |
|
|
2024
Q2 | $84.8M | Buy |
2,634,656
+615
| +0% | +$21.3K | 1.45% | 18 |
|
|
2024
Q1 | $102M | Buy |
2,634,041
+3,563
| +0.1% | +$125K | 1.6% | 14 |
|
|
2023
Q4 | $81M | Sell |
2,630,478
-856
| -0% | -$21.4K | 1.32% | 24 |
|
|
2023
Q3 | $58.8M | Buy |
2,631,334
+77
| +0% | +$1.76K | 1.06% | 31 |
|
|
2023
Q2 | $56.5M | Buy |
2,631,257
+1,120
| +0% | +$25.4K | 0.96% | 37 |
|
|
2023
Q1 | $63.1M | Buy |
2,630,137
+544
| +0% | +$14.4K | 1.16% | 25 |
|
|
2022
Q4 | $61M | Hold |
2,629,593
| – | – | 1.2% | 30 |
|
|
2022
Q3 | $42.1M | Hold |
2,629,593
| – | – | 0.83% | 46 |
|
|
2022
Q2 | $46.6M | Hold |
2,629,593
| – | – | 1% | 39 |
|
|
2022
Q1 | $53.5M | Hold |
2,629,593
| – | – | 0.84% | 43 |
|
|
2021
Q4 | $49.1M | Hold |
2,629,593
| – | – | 0.63% | 51 |
|
|
2021
Q3 | $51.9M | Hold |
2,629,593
| – | – | 0.69% | 46 |
|
|
2021
Q2 | $62.2M | Buy |
2,629,593
+201,617
| +8% | +$4.66M | 0.84% | 43 |
|
|
2021
Q1 | $57.5M | Hold |
2,427,976
| – | – | 0.85% | 42 |
|
|
2020
Q4 | $48.6M | Hold |
2,427,976
| – | – | 0.75% | 45 |
|
|
2020
Q3 | $50.5M | Hold |
2,427,976
| – | – | 1.01% | 33 |
|
|
2020
Q2 | $42.5M | Hold |
2,427,976
| – | – | 0.95% | 40 |
|
|
2020
Q1 | $39.6M | Hold |
2,427,976
| – | – | 1.32% | 26 |
|
|
2019
Q4 | $50M | Hold |
2,427,976
| – | – | 1.41% | 24 |
|
|
2019
Q3 | $27.9M | Hold |
2,427,976
| – | – | 0.92% | 41 |
|
|
2019
Q2 | $31.9M | Buy |
2,427,976
+220,366
| +10% | +$2.95M | 0.97% | 33 |
|
|
2019
Q1 | $33.4M | Hold |
2,207,610
| – | – | 1.15% | 27 |
|
|
2018
Q4 | $37.9M | Hold |
2,207,610
| – | – | 1.68% | 17 |
|
|
2018
Q3 | $32.5M | Hold |
2,207,610
| – | – | 1.2% | 29 |
|
|
2018
Q2 | $52.7M | Hold |
2,207,610
| – | – | 2.19% | 6 |
|
|
2018
Q1 | $56.4M | Hold |
2,207,610
| – | – | 2.64% | 3 |
|
|
2017
Q4 | $40.8M | Hold |
2,207,610
| – | – | 2.14% | 11 |
|
|
2017
Q3 | $23.2M | Hold |
2,207,610
| – | – | 1.31% | 32 |
|
|
2017
Q2 | $27.6M | Buy |
2,207,610
+53,998
| +3% | +$534K | 1.72% | 18 |
|
|
2017
Q1 | $21.7M | Buy |
2,153,612
+75,861
| +4% | +$1.13M | 1.43% | 30 |
|
|
2016
Q4 | $32.4M | Buy |
2,077,751
+67,473
| +3% | +$1.12M | 2.1% | 14 |
|
|
2016
Q3 | $38.7M | Buy |
2,010,278
+60,002
| +3% | +$713K | 2.36% | 11 |
|
|
2016
Q2 | $23.1M | Buy |
1,950,276
+84,998
| +5% | +$1.4M | 1.41% | 26 |
|
|
2016
Q1 | $33.9M | Buy |
1,865,278
+798,878
| +75% | +$14.5M | 1.89% | 14 |
|
|
2015
Q4 | $29.3M | Buy |
1,066,400
+90,982
| +9% | +$1.92M | 1.47% | 25 |
|
|
2015
Q3 | $21.6M | Buy |
975,418
+229,616
| +31% | +$4.15M | 1.25% | 28 |
|
|
2015
Q2 | $13.3M | Buy |
+745,802
| New | +$12.9M | 0.72% | 49 |
|
Other funds holding COLL
VCM
RCMNY